Roles of hnRNP A1, SR Proteins, and p68 Helicase in c-H-ras Alternative Splicing Regulation

REFERENCES

• Achsel, T., and Y. Shimura. 1996. Factors involved in the activation of pre-mRNA splicing from downstream splicing enhancers. J. Biochem. 120: 53–60.
   PubMedGoogle Scholar
• Bai, Y. D., D. Lee, T. D. Yu, and L. A. Chasin. 1999. Control of 3′ splice site choice in vivo by ASF/SF2 and hnRNP A1. Nucleic Acids Res. 27: 1126–1134.
   PubMedGoogle Scholar
• Blanchette, M., and B. Chabot. 1999. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J. 18: 1939–1952.
   PubMed Web of Science ®Google Scholar
• Blencowe, B. J. 2000. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25: 106–110.
   PubMed Web of Science ®Google Scholar
• Blencowe, B. J., R. Issner, J. A. Nickerson, and P. A. Sharp. 1998. A coactivator of pre-mRNA splicing. Genes Dev. 12: 996–1009.
   PubMedGoogle Scholar
• Bourgeois, C. F., M. Popielarz, G. Hildwein, and J. Stevenin. 1999. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5′ or 3′ splice site activation. Mol. Cell. Biol. 19: 7347–7356.
   PubMedGoogle Scholar
• Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550–553.
   PubMed Web of Science ®Google Scholar
• Burd, C. G., and G. Dreyfuss. 1994. RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13: 1197–1204.
   PubMed Web of Science ®Google Scholar
• Caceres, J. F., S. Stamm, D. M. Helfman, and A. R. Krainer. 1994. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265: 1706–1709.
   PubMed Web of Science ®Google Scholar
• Caputi, M., A. Mayeda, A. R. Krainer, and A. M. Zahler. 1999. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 18: 4060–4067.
   PubMedGoogle Scholar
• Caputi, M., and A. M. Zahler. 2002. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. EMBO J. 21: 845–855.
   PubMed Web of Science ®Google Scholar
• Carlo, T., R. Sierra, and S. M. Berget. 2000. A 5′ splice site-proximal enhancer binds SF1 and activates exon bridging of a microexon. Mol. Cell. Biol. 20: 3988–3995.
   PubMed Web of Science ®Google Scholar
• Carrascal, M., S. Carujo, O. Bachs, and J. Abian. 2002. Identification of p21Cip1 binding proteins by gel electrophoresis and capillary liquid chromatography microelectrospray tandem mass spectrometry. Proteomics 2: 455–468.
   PubMedGoogle Scholar
• Carstens, R. P., E. J. Wagner, and M. A. Garcia-Blanco. 2000. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Mol. Cell. Biol. 20: 7388–7400.
   PubMedGoogle Scholar
• Cartegni, L., M. Maconi, E. Morandi, F. Cobianchi, S. Riva, and G. Biamonti. 1996. hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J. Mol. Biol. 259: 337–348.
   PubMed Web of Science ®Google Scholar
• Cavaloc, Y., C. F. Bourgeois, L. Kister, and J. Stevenin. 1999. The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA 5: 468–483.
   PubMed Web of Science ®Google Scholar
• Chabot, B., M. Blanchette, I. Lapierre, and H. LaBranche. 1997. An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol. Cell. Biol. 17: 1776–1786.
   PubMedGoogle Scholar
• Chew, S. L., H. X. Liu, A. Mayeda, and A. R. Krainer. 1999. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 96: 10655–10660.
   PubMedGoogle Scholar
• Codony, C., S. Guil, C. Caudevilla, D. Serra, G. Asins, A. Graessmann, F. G. Hegardt, and M. Bach-Elias. 2001. Modulation in vitro of H-ras oncogene expression by trans-splicing. Oncogene 20: 3683–3694.
   PubMedGoogle Scholar
• Cohen, J. B., S. D. Broz, and A. D. Levinson. 1989. Expression of the H-ras proto-oncogene is controlled by alternative splicing. Cell 58: 461–472.
   PubMed Web of Science ®Google Scholar
• Cohen, J. B., S. D. Broz, and A. D. Levinson. 1993. U1 small nuclear RNAs with altered specificity can be stably expressed in mammalian cells and promote permanent changes in pre-mRNA splicing. Mol. Cell. Biol. 13: 2666–2676.
   PubMed Web of Science ®Google Scholar
• Del Gatto, F., A. Plet, M. C. Gesnel, C. Fort, and R. Breathnach. 1997. Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 17: 5106–5116.
   PubMedGoogle Scholar
• Del Gatto, F., and R. Breathnach. 1995. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 15: 4825–4834.
   PubMedGoogle Scholar
• Dirksen, W. P., R. K. Hampson, Q. Sun, and F. M. Rottman. 1994. A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J. Biol. Chem. 269: 6431–6436.
   PubMedGoogle Scholar
• Dreyfuss, G., M. J. Matunis, S. Pinolroma, and C. G. Burd. 1993. hnRNP proteins and the biogenesis of messenger RNA. Annu. Rev. Biochem. 62: 289–321.
   PubMed Web of Science ®Google Scholar
• Dye, D. T., M. Buvoli, S. A. Mayer, C. H. Lin, and J. G. Patton. 1998. Enhancer elements activate the weak 3′ splice site of α-tropomyosin exon 2. RNA 4: 1523–1536.
   PubMedGoogle Scholar
• Eperon, I. C., D. C. Ireland, R. A. Smith, A. Mayeda, and A. R. Krainer. 1993. Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. EMBO J. 12: 3607–3617.
   PubMedGoogle Scholar
• Eperon, I. C., O. V. Makarova, A. Mayeda, S. H. Munroe, J. F. Caceres, D. G. Hayward, and A. R. Krainer. 2000. Selection of alternative 5′ splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol. Cell. Biol. 20: 8303–8318.
   PubMedGoogle Scholar
• Fu, X. D. 1995. The superfamily of arginine/serine-rich splicing factors. RNA 1: 663–680.
   PubMed Web of Science ®Google Scholar
• Gallego, M. E., R. Gattoni, J. Stevenin, J. Marie, and A. Expert-Bezancon. 1997. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the β-tropomyosin alternative exon 6A. EMBO J. 16: 1772–1784.
   PubMed Web of Science ®Google Scholar
• Graveley, B. R. 2000. Sorting out the complexity of SR protein functions. RNA 6: 1197–1211.
   PubMed Web of Science ®Google Scholar
• Guo, W., G. J. Mulligan, S. Wormsley, and D. M. Helfman. 1991. Alternative splicing of β-tropomyosin pre-mRNA: cis-acting elements and cellular factors that block the use of a skeletal muscle exon in nonmuscle cells. Genes Dev. 5: 2096–2107.
   PubMedGoogle Scholar
• Hertel, K. J., and T. Maniatis. 1998. The function of multisite splicing enhancers. Mol. Cell 1: 449–455.
   PubMed Web of Science ®Google Scholar
• Honig, A., D. Auboeuf, M. M. Parker, B. W. O'Malley, and S. M. Berget. 2002. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Mol. Cell. Biol. 22: 5698–5707.
   PubMed Web of Science ®Google Scholar
• Huh, G. S., and R. O. Hynes. 1993. Elements regulating an alternatively spliced exon of the rat fibronectin gene. Mol. Cell. Biol. 13: 5301–5314.
   PubMedGoogle Scholar
• Humphrey, M. B., J. Bryan, T. A. Cooper, and S. M. Berget. 1995. A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol. Cell. Biol. 15: 3979–3988.
   PubMedGoogle Scholar
• Jensen, K. B., K. Musunuru, H. A. Lewis, S. K. Burley, and R. B. Darnell. 2000. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc. Natl. Acad. Sci. USA 97: 5740–5745.
   PubMed Web of Science ®Google Scholar
• Jin, W., E. S. Huang, W. Bi, and G. J. Cote. 1998. Exon sequence is required for regulated RNA splicing of the human fibroblast growth factor receptor-1 α-exon. J. Biol. Chem. 273: 16170–16176.
   PubMedGoogle Scholar
• Kohtz, J. D., S. F. Jamison, C. L. Will, P. Zuo, R. Luhrmann, M. A. Garciablanco, and J. L. Manley. 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368: 119–124.
   PubMed Web of Science ®Google Scholar
• Krecic, A. M., and M. S. Swanson. 1999. hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 11: 363–371.
   PubMed Web of Science ®Google Scholar
• Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860–921.
   PubMed Web of Science ®Google Scholar
• Lavigueur, A., H. Labranche, A. R. Kornblihtt, and B. Chabot. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with Sr proteins and stimulates U2-snRNP binding. Genes Dev. 7: 2405–2417.
   PubMed Web of Science ®Google Scholar
• Lerga, A., M. Hallier, L. Delva, C. Orvain, I. Gallais, J. Marie, and F. Moreau-Gachelin. 2001. Identification of an RNA binding specificity for the potential splicing factor TLS. J. Biol. Chem. 276: 6807–6816.
   PubMed Web of Science ®Google Scholar
• Li, H. P., X. Zhang, R. Duncan, L. Comai, and M. M. Lai. 1997. Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc. Natl. Acad. Sci. USA 94: 9544–9549.
   PubMed Web of Science ®Google Scholar
• Liu, H. X., S. L. Chew, L. Cartegni, M. Q. Zhang, and A. R. Krainer. 2000. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol. Cell. Biol. 20: 1063–1071.
   PubMed Web of Science ®Google Scholar
• Liu, Z. R. 2002. p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5′ splice site duplex. Mol. Cell. Biol. 22: 5443–5450.
   PubMed Web of Science ®Google Scholar
• Lopez, A. J. 1998. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu. Rev. Genet. 32: 279–305.
   PubMed Web of Science ®Google Scholar
• Lou, H., D. M. Helfman, R. F. Gagel, and S. M. Berget. 1999. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3′-terminal exon. Mol. Cell. Biol. 19: 78–85.
   PubMedGoogle Scholar
• Marchand, V., A. Mereau, S. Jacquenet, D. Thomas, A. Mougin, R. Gattoni, J. Stevenin, and C. Branlant. 2002. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. J. Mol. Biol. 323: 629–652.
   PubMedGoogle Scholar
• Marshall, C. J. 1996. Ras effectors. Curr. Opin. Cell Biol. 8: 197–204.
   PubMed Web of Science ®Google Scholar
• Mathews, D. H., J. Sabina, M. Zuker, and D. H. Turner. 1999. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288: 911–940.
   PubMed Web of Science ®Google Scholar
• Mayeda, A., D. M. Helfman, and A. R. Krainer. 1993. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol. Cell. Biol. 13: 2993–3001.
   PubMed Web of Science ®Google Scholar
• Mayeda, A., and A. R. Krainer. 1992. Regulation of alternative pre-messenger-RNA splicing by hnRNP-A1 and splicing factor-SF2. Cell 68: 365–375.
   PubMed Web of Science ®Google Scholar
• Min, H. S., C. W. Turck, J. M. Nikolic, and D. L. Black. 1997. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev. 11: 1023–1036.
   PubMedGoogle Scholar
• Stoss, O., M. Olbrich, A. M. Hartmann, H. Konig, J. Memmott, A. Andreadis, and S. Stamm. 2001. The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites. J. Biol. Chem. 276: 8665–8673.
   PubMedGoogle Scholar
• Sun, Q., A. Mayeda, R. K. Hampson, A. R. Krainer, and F. M. Rottman. 1993. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7: 2598–2608.
   PubMed Web of Science ®Google Scholar
• Tacke, R., Y. Chen, and J. L. Manley. 1997. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. Proc. Natl. Acad. Sci. USA 94: 1148–1153.
   PubMed Web of Science ®Google Scholar
• Tacke, R., and J. L. Manley. 1999. Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11: 358–362.
   PubMedGoogle Scholar
• Tacke, R., and J. L. Manley. 1995. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14: 3540–3551.
   PubMed Web of Science ®Google Scholar
• Wang, Z., H. M. Hoffmann, and P. J. Grabowski. 1995. Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. RNA 1: 21–35.
   PubMed Web of Science ®Google Scholar
• Watakabe, A., K. Tanaka, and Y. Shimura. 1993. The role of exon sequences in splice site selection. Genes Dev. 7: 407–418.
   PubMed Web of Science ®Google Scholar
• White, M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533–541.
   PubMed Web of Science ®Google Scholar
• Wu, J. I., R. B. Reed, P. J. Grabowski, and K. Artzt. 2002. Function of quaking in myelination: regulation of alternative splicing. Proc. Natl. Acad. Sci. USA 99: 4233–4238.
   PubMed Web of Science ®Google Scholar
• Yang, L., L. J. Embree, S. Tsai, and D. D. Hickstein. 1998. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 273: 27761–27764.
   PubMed Web of Science ®Google Scholar
• Zahler, A. M. 1999. Purification of SR protein splicing factors. Methods Mol. Biol. 118: 419–432.
   PubMedGoogle Scholar
• Zhu, J., A. Mayeda, and A. R. Krainer. 2001. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell 8: 1351–1361.
   PubMedGoogle Scholar
• Zinszner, H., R. Albalat, and D. Ron. 1994. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 8: 2513–2526.
   PubMedGoogle Scholar